Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Current Biology : CB|January 1, 2008
TORC1 is essential for NF1-associated malignanciesCory M Johannessen, Bryan W Johnson, Sybil M Genther Williams, et al.Cancer Research|January 6, 2026
EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Pro-apoptotic RegulatorsNaiara Perurena, Marina Watanabe, Amy E Schade, et al.Cancer Discovery|November 23, 2012
Elucidating distinct roles for NF1 in melanomagenesisOphélia Maertens, Bryan Johnson, Pablo Hollstein, et al.Cancer Cell|May 29, 2018
Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress ToleranceNobuaki Takahashi, Hsing-Yu Chen, Isaac S Harris, et al.Nature|August 15, 2014
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapiesThomas De Raedt, Eline Beert, Eric Pasmant, et al.Cancer Research|October 11, 2017
A Collaborative Model for Accelerating the Discovery and Translation of Cancer TherapiesOphélia Maertens, Mila E McCurrach, Benjamin S Braun, et al.Cancer Immunology Research|March 13, 2020
IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant TumorsTian Tian, Serena Lofftus, Youdong Pan, et al.Cell|February 28, 2015
Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapyJoan Montero, Kristopher A Sarosiek, Joseph D DeAngelo, et al.The Journal of Clinical Investigation|June 29, 2023
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancerFrancesca Nardi, Naiara Perurena, Amy E Schade, et al.Cancer Discovery|December 16, 2016
Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast CancersSarah Naomi Olsen, Ania Wronski, Zafira Castaño, et al.Pageof 6